Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecAiforia TechnologiesBiohitOrionModulight

Latest content

ShowingAll content types

Aiforia H1'26: Still a long way to go before reaching profitability

Research 31.08.2026, 13.26 by Antti Siltanen, Antti Luiro
Aiforia Technologies

Faron H1'26: New trials set to get underway

Research 27.08.2026, 10.20 by Antti Siltanen
Faron Pharmaceuticals

Aiforia lands new partnership in breast cancer diagnostics

Analyst Comment 26.08.2026, 09.59 by Antti Siltanen
Aiforia Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Aiforia H1'26 preview: Profit warning increased concerns about commercial progress

Analyst Comment 26.08.2026, 12.00 by Antti Siltanen
Aiforia Technologies

Faron H1'26 preview: BEXERA trial is being initiated

Analyst Comment 25.08.2026, 09.37 by Antti Siltanen
Faron Pharmaceuticals

Modulight Q2'26: Pricing under pressure

Research 24.08.2026, 10.20 by Antti Siltanen
Modulight

Herantis H1'26: Phase 2 preparation is progressing

Research 21.08.2026, 09.08 by Antti Siltanen
Herantis Pharma

Biohit: GastroPanel Quick Test also works during proton pump inhibitor therapy

Analyst Comment 19.08.2026, 08.27 by Antti Siltanen
Biohit

Nightingale's remote tests to be included in Supernormal's weight loss service

Analyst Comment 19.08.2026, 09.12 by Antti Siltanen
Nightingale Health

Modulight Q2'26 preview: Savings measures likely to improve earnings while revenue declines

Analyst Comment 19.08.2026, 09.22 by Antti Siltanen
Modulight